- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
VODOCAT REPORT AT THE DEPARTMENT OF RENAL ENTRY – UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL 1, HCMC
On August 8, 2023, Medbolide Joint Stock Company cooperated with the Department of Nephrology - Ho Chi Minh City University of Medicine and Pharmacy Hospital - to organize an information session on the drug VODOCAT (Torsemide 5 mg). The drug information session was chaired by M.D. Huynh Ngoc Phuong Thao - Head of the Department of Nephrology - and attended by more than 20 kidney specialists.
Company representatives shared about the diuretic mechanism and cardiovascular benefits of Torsemide. Clinical studies and recommendations from prestigious specialist associations around the world.
Through the drug information session, doctors at Ho Chi Minh City University of Medicine and Pharmacy Hospital have a better understanding of Torsemide and how to use it for their patients. Medbolide Joint Stock Company always strives to provide doctors with the latest and most accurate drug information, contributing to improving the quality of treatment and improving the health of Vietnamese people.
Readers comments